LINDSEY MILLER: Open Payments
NPI 1548916232 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$763 in 31 payments from 22 companies in 2025. Trend: 2023 $453 · 2024 $510 · 2025 $763
Food & beverage: $763
| Company | Payments | Amount |
|---|---|---|
| Tempus AI, Inc | 1 | $100 |
| Merck Sharp & Dohme LLC | 4 | $94 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $85 |
| Novartis Pharmaceuticals Corporation | 4 | $85 |
| Aveo Pharmaceuticals, Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $37 |
| Janssen Biotech, Inc. | 2 | $30 |
| SHORLA ONCOLOGY INC. | 1 | $26 |
| TerSera Therapeutics LLC | 1 | $25 |
| Mallinckrodt Hospital Products Inc. | 1 | $24 |
Products named: XT CDX, KEYTRUDA, XIFAXAN, SCEMBLIX, FOTIVDA, KISQALI, VERZENIO, IMKELDI.
Industry payments across OH — which companies pay providers there.
